Finally, transcriptomic alterations induced by rosuvastatin were limited to genes involved in cholesterol biosynthesis.<h4>Conclusion</h4>We have established HMGCR as a regulator of GLP-1 secretion and provide a plausible explanation for the clinically observed mild hyperglycemia associated with statin use. The gene discussed is HMGCR; the disease is Hyperglycemia.